The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.
When it comes down, sources said, it will delineate who the favored sons are on the New Brunswick, N.J.-based client’s long roster. “It will be similar to what P&G and Unilever have done recently,” said one source.
However, some sources speculate that a new shop might pop up on the roster to handle Pepcid anti-ulcer drug, which is currently prescription only.
Exactly which brands will move has not been finalized, but agency executives said that Young & Rubicam and Cadwell Davis Partners will probably see their role on the agency roster diminished, if not broken off entirely.

WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in